RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:While other biotech steam forward. DUG looks behind the MrMugsy wrote: Yes ... Paladin is a cautionary tale of what to expect. A long and steady development of the network. If you buy into that then you will survive Knight. I f you don’t buy that then this stock will not fulfill you.
That’s the point.
Palladin was nothing but a fluke purchase caught up in a roll-up and tax bubble in drug stocks created by Valeant. This door is now closed. I can think of a few CEOs who took with similiar pedigrees, that took companies from a few dollars to large % returns. John Chen arrived to lead BlackBerry 7 years ago. Since he took Sybase from a few dollars to a $65 buyout many thought he's do it again and BB doubled/tripled for the first 1-2 years. Reality set in and it won't be happening again and BB is languising in single digits for YEARS. Same at Bausch with Joe Papa.
Comical to read your nonsense. You're here basically saying, with a big amount of certainty and supreme arrogance that a Palladin is guranteed to happen again. lol When in actual fact the price action is telling you it will not happen again.